期刊文献+

双丙戊酸钠、氟桂利嗪单用与合用预防偏头痛的疗效观察 被引量:3

Effects of flunarizine and divalproex administered alone and in combination in the prophylaxis of migraine
原文传递
导出
摘要 目的:观察氟桂利嗪、双丙戊酸钠及氟桂利嗪合用双丙戊酸钠对偏头痛发作的预防作用。方法:将124例偏头痛患者随机分为氟桂利嗪组(41例,A组)、双丙戊酸钠组(42例,B组)及氟桂利嗪合用双丙戊酸钠组(41例,C组),治疗2个月后对上述3组预防效果进行比较。结果:A组与B组总有效率分别为70.73%及73.81%,预防疗效差异无显著性(P<0.05),C组有效率92.68%,较A组、B组疗效好。结论:氟桂利嗪、双丙戊酸钠及氟桂利嗪合用双丙戊酸钠对偏头痛发作均有较好的预防作用,氟桂利嗪合用双丙戊酸钠较单独应用其中一种有更好的预防效果,但可能带来更多的不良反应。 OBJECTIVE To compare effects of flunarizine and divalproex administered alone and in combination in the proph ylaxis of migraine. METHODS 124 patients with migraine were distributed randomly into flunarizine group(n = 41, A group) , divalproex group(n = 42, B group) and flunarizine-divalproex group(n = 41 ,C group). After treatment of two months, the effective rates were compared among three groups. RESULTS The total effective rate was 70. 73% in A group and 73. 81% in B group, there was no significant difference between the two groups(P〈0. 05). The total effective rate in C group (92. 68%) were significant higher than that in groups A and B. CONCLUSION These results indicate that both flunarizine and divalproex are effective in migraine prophylaxis. Combination of two drugs have better effects than single drug but may cause more side effects.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2008年第24期2118-2119,共2页 Chinese Journal of Hospital Pharmacy
关键词 氟桂利嗪 双丙戊酸钠 偏头痛 divalproex flunarizine migraine
  • 相关文献

参考文献6

  • 1Silberstein SD, Goadsby PJ, Lipton RI. Management of migraine:an algorithmic approach[J]. Neuroh 2000,55 (suppl. 2) : 46.
  • 2乔向阳.头痛疾患的分类和诊断(指南)[J].继续医学教育,2005,19(3):74-78. 被引量:29
  • 3金雨来,黄流清.偏头痛预防药物研究进展[J].世界临床药物,2006,27(2):105-109. 被引量:6
  • 4Aurora SK, Ahmaol BK, Welch KI, et al. Transcranial magnetic stimulation confirms hyperexcitability of occipital cortex in migraine[J]. Neurology, 1998, 50(4) : 1111.
  • 5Mathew NT, Saper JR, Silberstein SD, et al. Migraine prophylaxis with divalproex[J]. Arch Neurol, 1995,52 (3) : 281-286.
  • 6Chronicle E, Mulleners W. Anticonvulsant drugs for migraine prophyiaxis[J]. Cochrane Database Syst Rev, 2t/04, 3: CD003226.

二级参考文献4

  • 1F. Moschiano,G. Allais,L. Grazzi,S. Usai,C. Benedetto,D. D’Amico,M. Roncolato,G. Bussone. Naratriptan in the short-term prophylaxis of pure menstrual migraine[J] 2005,Neurological Sciences(2):s162~s166
  • 2F. Frediani. Anticonvulsant drugs in primary headaches prophylaxis[J] 2004,Neurological Sciences(3):s161~s166
  • 3Prof.Dr. Hans-Christoph Diener,P. Tfelt-Hansen MD, PhD,C. Dahl?f MD, PhD,M. J. A. Láinez MD, PhD,G. Sandrini MD,Sh.-J. Wang MD,W. Neto MD,U. Vijapurkar PhD,A. Doyle MD,D. Jacobs MD. Topiramate in migraine prophylaxis[J] 2004,Journal of Neurology(8):943~950
  • 4K. Vahedi,P. Taupin,R. Djomby,M. El-Amrani,G. Lutz,V. Filipetti,P. Landais,H. Massiou,M. G. Bousser. Efficacy and tolerability of acetazolamide in migraine prophylaxis: A randomised placebo-controlled trial[J] 2002,Journal of Neurology(2):206~211

共引文献32

同被引文献35

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部